About A4I
Analysis for Innovators can help boost productivity and competitiveness in your business through solving existing problems.
A4I is a programme that gives UK businesses of any size access to cutting-edge R&D expertise and facilities to help solve problems that they have been unable to tackle using standard technologies and techniques. It might be around product reliability, cost or product lifetime.
Details of Round 5: (competitions now closed)
A4I Round 5: phase 1 expression of interest (de minimis)
A4I Round 5: phase 1 expression of interest
Impact
- 205Successful EOIs
- 303Brokerage Meetings
- 121Projects Funded
- £12.2 millionProject Costs
- £8.5 millionGovernment Contributions
- £3.7 millionCompany Contributions
Case Studies
Sistemic
Supporting the development of a novel product to ensure the safety of cell therapy treatments
Cell therapies, where living cells are transplanted in to a patient, are seen as the future of treatment in a number of therapeutic areas including diabetes and cardiovascular disease.
Lean Manufacturing & Assembly Technologies
Measuring how much materials shrink during manufacture
National Physics Laboratory measurements improve model used to ensure that composite aircraft structures and wind turbine blades meet design specifications.
Gold Standard Phantoms
NPL validates new MRI standard, advancing potential technique for Alzheimer’s diagnosis
MRI scanners are pivotal to diagnosing a wide range of conditions, but with new measurement approaches, they could be used to diagnose many more.
News
Posted 28/05/2020
Sixfold expands its portfolio of collaborative projects
Sixfold Bioscience, a biotechnology company focused on the development of drug delivery systems for gene therapeutics, has been awarded a third grant through the ‘Analysis for Innovators’ (A4I) programme co-funded by the UK’s innovation agency — Innovate UK. The project will expand the capabilities of Sixfold’s proprietary delivery systems.
Read more
Posted 18/12/2019
Sixfold Bioscience awarded two Innovate UK grants through the A4I programme
Sixfold Bioscience awarded two Innovate UK grants to advance the development of their cell and gene therapeutic delivery system.
Read more
Posted 11/09/2019
Jellagen® launches their first purified jellyfish collagen hydrogel: JellaGelTM
Jellyfish collagen set to revolutionise in vitro cell culture and tissue engineering.
